Study Assessed the Safety and Efficacy of Eltrombopag in Chinese Refractory or Relapsed Severe Aplastic Anemia (SAA) Subjects.
Clinical trial NCT03988608 · COMPLETED
Trial details
- NCT number
- NCT03988608
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-12-09
- Primary completion
- 2021-07-16
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.